SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001104659-22-028119
Filing Date
2022-02-28
Accepted
2022-02-28 16:30:29
Documents
1
Group Members
JCP III SM AIV, L.P.JUGGERNAUT PARTNERS III GP, L.P.JUGGERNAUT PARTNERS III GP, LTD.METP HOLDINGS, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13D/A tm227880d1_sc13da.htm SC 13D/A 97994
  Complete submission text file 0001104659-22-028119.txt   99308
Mailing Address
Business Address
SHULMAN JOHN D (Filed by) CIK: 0001208886 (see all company filings)

Type: SC 13D/A

Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 973-242-0005
Petros Pharmaceuticals, Inc. (Subject) CIK: 0001815903 (see all company filings)

IRS No.: 851410058 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-91895 | Film No.: 22690185
SIC: 2834 Pharmaceutical Preparations